Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) traded up 3.3% during trading on Wednesday . The company traded as high as $39.48 and last traded at $39.14. 2,798 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 160,858 shares. The stock had previously closed at $37.89.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on the company. Truist Financial upped their price target on Astrana Health from $41.00 to $44.00 and gave the company a "hold" rating in a research note on Friday, March 1st. Jefferies Financial Group began coverage on Astrana Health in a research note on Monday, February 26th. They set a "buy" rating and a $50.00 target price for the company.
Read Our Latest Analysis on Astrana Health
Astrana Health Stock Performance
The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. The company has a market capitalization of $2.07 billion, a PE ratio of 28.63, a P/E/G ratio of 1.28 and a beta of 1.09.
Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.09. The business had revenue of $353.00 million during the quarter, compared to analysts' expectations of $341.17 million. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. Astrana Health's revenue for the quarter was up 20.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.02 EPS. On average, analysts anticipate that Astrana Health, Inc. will post 1.62 earnings per share for the current year.
About Astrana Health
(
Get Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
